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We recently reported the production of a human monoclonal 
antibody (MoAb) derived from a patient with pemphigus 
vulgaris (PV) that binds to the .kerati~ocyte membrane afold 
reacts with a 185-kD polypeptide by tmmunoblot analysts. 
We have since examined the tissue specificity of that MoAb, 
F12. By indirect immunofluorescence (IIF), F12 stained both 
the cell membrane and the basement membrane zone of 
stratified squamous epithelia. Moreover, MoAb F12 stained 
other epithelial tissues, such as urinary bladder, small bowel, 
thymus, and liver, and non-epithelial tissues, such as myoc~­
dium. Indirect immunoelectron microscopy (HEM) analysts 
showed that MoAb F12 bound to a component common to 
desmosomal and hemidesmosomal plaques and to zona ad-
herens-type junctions between hepatocytes and bile duct 
cells. 
Inhibition experiments were then performed with sera 
Pemphigus comprises a group of autoimmune skin dis-eases characterized by intraepithelial blisters caused by a variety of autoantibodies directed against keratinocyte surface proteins [1]. Different clinical and immunologic forms of pemphigus have been described. Pemphigus 
vulgaris is characterized by the production of autoantibodies di-
rected against a 210-kD complex formed by a 130-kD antigen asso-
ciated with plakoglobin, a desmosomal protein [2]. In pemphigus 
foliaceus, autoantibodies are directed against desmoglein, a 160-kD, 
desmosomal protein, which is also associated with plakoglobin [3]. 
Recently, a new type of pemphigus associated with various neoplas-
tic conditions has been identified [4]. Autoantibodies from patients 
with these paraneoplastic pemphigus reacted with an antigen com-
plex composed of desmoplakin I and II, the 230-kD antigen of 
bullous pemphigoid, and an as-yet unidentified epithelial antigen of 
190 kD. 
We recently described a human monoclonal antibody (MoAb) 
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from patients with pemphigus vulgaris, pemphigus foliaceus, 
paraneoplastic pemphigus, or bullous pemphigoid. Three 
sera bl~cked F!2 reactivity; two were from paraneoplastic 
pemp~tgus patients and the other was from the pemphigus 
vulgans pattent whose peripheral blood lymphocytes were 
used to m~ke F12. ~ll these sera recognized a 185-kD band 
tha~ co-mtgrated wtth the polypeptide labeled by MoAb F12 
on tmmunoblots. In addition, the IIF and HEM staining pat-
terns of MoAb F12 were similar to those observed with sera 
from ~o patients with paraneoplastic pemphigus. These ob-
servatlOns suggest a relationship between MoAb F12 and the 
autoimmune response characterizing paraneoplastic pem-
phigus patients' sera. Key words: human monoclonal au-
toantibody jpemphigus antigen. J Invest Dermatol 101 :339-
345, 1993 
derived from a patient with pemphigus vulgaris [5]. This MoAb 
bi~ds to the cell surface ~f stratified squamous epithelia and reacts 
With a 18?-k~ polypeptide by unmunoblot analysis using bovine 
tongue eplthehum as the substrate. In this study, we used indirect 
immunofluorescence (II F) labeling to explore the tissue specificity 
of this MoAb, ~12.' and indir~ct immunoelectron microscopy 
(~IEM~ to determme Its ultralocahzation. We also analyzed the rela-
tionships b~tween !"l0Ab .F12 and t.he autoantibodies present in the 
sera .of patients. With vano.us autOImmune blistering diseases, in-
cludm& pemphigus vulgarIS, pemphigus foliaceus, paraneoplastic 
pemphigus, and bullous pemphigoid. 
MATERIALS AND METHODS 
Monoclonal Antibody.F12 The MOAb-secreting hybridoma, F12, was 
es~bhsh~d by fusll1g peripheral blood lymphocytes from a pemphigus vul-
gans patIent and a heteromyeloma cell line (5). The MoAb belongs to the 
immunoglobulin M, kappa class. 
Indirect Immu.nofluorescence Analysis IIF staining was used to study 
MoAb F12 labelmg of these dIfferent substrates: adult human skin obtained 
during plastic surgery, fetal human skin at an estimated gestational age of20 
weeks, munne and human small and large intestines, human and rat blad-
d~rs, monkey esophagus, rat and bovine tongues, rat liver, mouse myocar-
dIUm, and thymus. Tissues were frozen in liquid nitrogen and stored at 
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-70°C until used. Four-micron-thick cryostat sections were prepared and 
allowed to air-dry at room temperature. Unfixed sections were incubated 
with different dilutions of the supernatant of the MoAb-secreting hybri-
doma in a moist chamber for 30 min and washed twice with phosphate-buf-
fered saline (PBS). Tissues were then incubated with fluorescein isothio-
cyanate (FlTC) -conjugated goat anti-human IgM diluted 1 : 20 (Diagnostic 
Pasteur, Marnes La Coquette, France) for 40 min. After being washed with 
PBS, the sections were examined under a Leitz Orthoplan fluorescent mi-
croscope equipped with standard filters . Controls included two human IgM 
MoAb, one with anti-smooth muscle activity and the other with anti-reticu-
lum activity, and were derived from different fusion experiments. 
Human epidermal cel l suspensions were isolated as previously described 
[6]. Briefly, normal human skin was incubated in a 0.25% trypsin solution 
(Gibco-BRL, Cergy Pontoise, France) in RPMI medium at 37"C for 1 h. 
The epidermis was then transferred into RPM I medium supplemented with 
10% fetal bovine serum (FBS) (Gibco-BRL) and dissociated by gentle agita-
tion. The suspension was separated from the stratum corneum by gauze 
filtration. Dissociated ce lls were centrifuged at 200 X g for 5 min and 
washed three times in Hanks' balanced salt solution (HBSS) (approximately 
95% of these ce lls excluded try pan blue dye). IIF studies were performed on 
cytospin preparations of unfixed keratinocytes. 
Immunofluorescence Blocking Experiments Different sera were 
used in the blocking assays: ten pemphigus vulgaris, two pemphigus folia-
ceus, two para neoplastic pemphigus, and four bullous pemphigoid sera, one 
serum containing "pemphigus-like antibodies" obtained from a burn pa-
tient, and four sera from healthy subjects. The two paraneoplastic pemphi-
gus sera were from a chi ld with diffuse large-cell non-immunoblastic nodal 
lymphoma and a 42-year-old man with diffuse mixed small - and large-ce ll 
nodal lymphoma. Both patients developed urticaria and bullous skin lesions 
associated with severe oral and conjunctival mucosal involvement. All the 
diseased sera were shown to label human skin sections by IIF when FITC-
conjugated goat anti-human IgG (Diagnostic Pasteur) was used to visualize 
them but no positive reaction was seen when FITC-conjugated goat anti-
IgM was used to reveal them. Thus, the absence of autoantibodies of the IgM 
class in t~ese sera allowed the lise of FITC-conjugated goat anti-IgM to 
selectively probe for the presence of MoAb F12 in the immunofluorescence 
blocking experiments. Two murine MoAbs directed against desmoglein I or 
desmoplakin I-II (50 )1g/ml) (Progen-Biotechnik, Heidelberg, Germany) 
were also used in the blocking assays. The F12 supernatant was concentrated 
by ammonium sulfate precipitation and used at the concentration of 10 
)1g/ml. Sera from patients and healthy controls were tested at various dilu-
tions ranging from 1: 3 to 1: 50. Anti-desmoglein and anti-desmoplakin 
MoAb were used at dilutions ranging from 1 : 2 to 1 : 32. 
The experiments were performed as follows. Human skin sections were 
first incubated with test sera, anti-desmoglein, or anti-desmoplakin MoAb 
for 30 min, then washed with PBS, and subsequently incubated with MoAb 
F12 (10 pg/ml) for 30 min. The sections were washed with PBS and incu-
bated with a 1 : 20 dilution of FITC-conjugated goat anti-human IgM 
(Diagnostic Pasteur). Only complete inhibitions were taken into considera-
tion. 
Immunoelectron Microscopy Indirect immunoperoxidase reactions 
were performed on unfixed normal human skin, normal human oral mucosa, 
isola ted keratinocytes, and rat liver [7]. Samples were sl iced into 0.7-mm-
thick sections, washed with agitation in HBSS, and incubated with the 
MoAb F12 diluted in HBSS overnight at 4°C. After washing in HBSS, the 
samples were incubated with peroxidase-labeled goat anti-human immuno-
globulins (Biosys S.A., Compiegne, France), diluted 1 : 10 in HESS, for 22 h 
at 4°C. After washing, the skin samples were fixed in Karnovsky's fixative 
for 3 h at 4°C. The peroxidase activity was then revealed with dimethylar-
sinic acid buffer (Sigma Chemical Co., St. Louis, MO) for 1 h at room 
temperature. After washing, the tissue samples were post-fixed in the same 
buffer with 0.2 M HCI, pH 7.4 for 10 min, washed, and embedded in epoxy. 
Grids were not counterstained for IIEM examination. The supernatant of a 
hybridoma secreting a human IgM MoAb with no detectable antigenic 
specificity was used as the control. 
Immunoblots Immunoblotting was performed according to a previously 
described method (8) with slight modifications. Bovine tongue was obtained 
from a freshly slaughtcred animal. The epithelium with its attached connec-
tive tissue was minced finely with scissors and cxtracted with ice-cold 
0.0625 M Tris-HCI, pH 6.8, 2% sodium dodccyl sulfate (SDS) in the pres-
ence of phcnylmethylsulfonyl fluoride (PMSF) (Sigma) and 10 pg/ml of 
each of the following protease inhibitors: Icupeptin, antipain, chymostatin, 
and pepstatin (Sigma) . The suspension was ultrasonicatcd at setting 6 for 15 
seconds (microultrasonic cell disrupter) and centrifuged at 15,000 rpm for 
1 h at 4 dc. The resu lting supernatant was boiled for 2 min and aliquots were 
frozen at -70°C. SDS - polyacrylamide gel electtophoresis (PAGE) was 
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performed using a 6% separative gel. The proteins were electrophoretically 
transferred onto nitrocellulose filters (24 V for 2 h) in 12.5 mM Tris-OH, 
96 mM glycine buffer with 20% (v Iv) methano!' The remaining binding 
sites on the filter replica of the gel were then saturated by immersion for 1 h 
at room temperature in PBS containing 5% (v Iv) milk powder. Longitudinal 
strips of the filter were cut and incubated for 1 h with either a 1 : 40 dilution 
of the test serum in PBS containing 5% milk powder and 0.1 % Tween 20 or 
F12 supernatant, or anti-desmoglein 1 or anti-desmoplakin I-II murine 
MoAb. After three washes in PBS, the strips were incubated with horserad-
ish peroxidase -conjugated goat anti-human IgG Or IgM (Nordic Immuno-
logical Laboratories, Tilburg, The Netherlands) or goat anti-lllurine IgG 
(Nordic Immunological Laboratories) diluted 1 : 1000 in PBS-O.l % Tween 
20-5% milk powder for 1 h at room temperature. After washing with PBS-
0.1 % Tween 20, the peroxidase activity was revealed with D-aminobenzi-
dine (Sigma) [8]. Inhibition experiments were performed by preincubating 
the strips with 1 : 20 dilution of the test serum. After washing, the strip was 
incubated with MoAb F12 and processed as described above. 
RESULTS 
Indirect Immunofluorescence Studies 
Stratified Squamous Epithelia as Substrates: MoAb F12 was incu-
bated on sections of the following stratified squamous epithelia: 
human skin, monkey esophagus, rat, and bovine tongues. Compa-
rable fine linear labeling of the cell membrane from the basal cell 
layer to the stratum spinosum was observed on these substrates. The 
upper limit of the staining was clear-cut, with no staining of the 
stratum granulosum or the stratum corneum (Fig 1A). In addition, 
linear-granular deposits were present along the basement mem-
brane zone (BMZ) (Fig 1A). IIF on approximately 20-week gesta-
tional age human fetal skin with MoAb F12 sh owed a similar pat-
tern of cell membrane and BMZ staining (Fi g lB). This particular 
fluorescent pattern on human skin differed froni that seen with sera 
from pemphigus vulgaris patients (Fig IC), which did not label the 
BMZ, but was very similar to the staining observed with sera from 
paraneoplastic pemphigus patients (Fig ID). 
Epidermal Cell Suspension as th e Substrate: MoAb F12 was also used 
to label isolated keratinocytes. A fine patchy fluorescent pattern was 
observed on unfixed keratinocytes, suggesting an irregular distribu-
tion of the antigen on the keratinocyte membrane (Fig 2A). This 
fluorescent pattern was quite similar to that obtained with anti-des-
moplakin and anti-plakoglobin mouse MoAbs on the same prepara-
tion of freshly isolated cells (data not shown). The immunostaining 
of unfixed keratinocytes by MoAb directed against intracellular 
components was surprising. But it is very likely that the cytospin 
procedure used was responsible for the alteration of the keratinocyte 
membrane. 
Other Epithelia as the Substrates: Fine cell membrane and strong 
BMZ staining was observed on human and rat urinary bladder (Fig 
2B). On small intestine sections, MoAb F12 gave a linear fluores-
cent band along the apical surface of the enterocytes (Fig 2C) , which 
might correspond to desmosomal structures localized just below the 
striated border of these cells. Epithelial cells of murine thymus were 
also stained with the human MoAb (not shown). Rat liver sections 
stained by MoAb Fl2 exhibited a fluorescent pattern localized in the 
hepatocyte membrane regions in contact with bile duct cells (Fig 
2D). Concerning non-epithelial substrates, MoAb F12 intensely 
labeled the intercalated disks of mouse heart myocardium [5] . In 
contrast, no staining was observed when the MoAb Fl2 was tested 
on brain, chest, spleen, and lymph node sections (data not shown). 
Immunofluorescence Blocking Experiments To determine 
the relationship between MoAb F12 and autoantibodies present in 
sera from patients with various autoimmune blistering diseases, IIF 
blocking assays were performed using human skin sections as the 
substrate. Ten pemphigus vulgaris, two pemphigus foliaceus , twa 
paraneoplastic pemphigus, four bullous pemphigoid sera, one serum 
containing "pemphigus-like antibodies," and four sera from 
healthy subjects were first incubated with the sections to determine 
their capacity to block the binding of MoAb F12. Among these sera 
three inhibited the binding of F12 to the intercellular substance and 
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Figure 1. Indirect immunofluorescent l.abeling of stratified squamous epithelia. Four-micron - thick cryostat sections were incubated with MoAb F12 or 
patients' sera, washed, and mcubated With FITC-conJugated goat anti-human IgM or IgG. The F12 monoclonal antibody gave a lmear staining of the 
keratinocyte cel l membrane and a linear-granular staining ofBMZ on A.) normal human sk ll1 (bar, 20 11m) and B) human feta l ski n of approximately 20 weeks' 
gestational age (bar, 20 11m). Immunoflu orescent ana lysis of norma l human skin labeled with C) a pemphigus vulgaris serum that gave an intercel lular 
substance staining (bar, 20 11m) and D) a paraneoplastic pemphigus serum that gave "intercellular" substance and BMZ staining (bar, 25 11m). 
the BMZ. One serum diluted 1: 10 came from the pemphigus vul-
garis patient from w hom the MoAb F12 was derived and two se,:"a 
diluted 1 : 10 and 1: 20, respectively, were from paraneoplastlc 
pemphigus patients. N o blocking effect could be observed with the 
IgG anti-desmoglein or anti-desmoplakin murine MoAb or normal 
human sera (data not shown) . 
lnununoelectron Microscopy In HEM studies, F12 reacted 
positively on normal human skin and oral mucosa specimens, with 
labeling of the keratinocyte cell membrane and, more precisely, the 
desmosomal regions. No deposit was observed when an irrelevant 
human IgM monoclonal antibody was used as a control. Examina-
tion at higher magnification revealed that the peroxidase deposits 
l11volved desmosomal plaques (Fig 3A), but they were never de-
tected on the keratinocyte plasma membrane between desmosomes 
or in the extracellular portion of desmosomes. When the dermal-
epidermal junction was examined, peroxidase deposits were ob-
served exclusively on hemidesmosomes. Figure 3B shows that the 
positive reaction was loca lized on the hemidesmosomal plaques 
with no staining of the basal cytoplasmic membrane of the kerati-
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Figure 2. Indirect immunofluorescence of various e'pithelial and non-epithelial substrates using MoAb F12. A) On isolated keratinocytcs, MoAb F12 stained 
the cell membrane (bar, 4 Jim); B) on rat urinary bladder, a strong fluorescence of the DMZ was observed (bar, 4 ~L!n); C) on murine small bowel, MoAb F12 
labeled the apical surface of the enterocytes (bar, 4 Jim); D) on rat liver, MoAb 1'12 stained the hepatocyte membrane regions in contact with bile duct cells (bar, 
4iJ.m). 
nocytes or the lamina lucida. Two sera from patients with paraneo-
plastic pemphigus were also analyzed by HEM; their staining pat-
terns of the dermal -epidermal junction were very similar to that 
obtained with MoAb F12 (Fig 3C). 
F12labeling ofkeratinocyte suspensions and rat liver sections was 
also studied by IIEM. On the former substrate, the positive reaction 
was localized on desmosomes with no staining of the keratinocyte 
plasma membrane between desmosomes. On the latter, the peroxi-
dase deposits were localized on the adherens-type junctions be-
tween hepatocytes and bile duct cells. No staining of the attached 
microfilaments or of the interjunctional regions of the hepatocyte 
membrane was seen (Fig 3D). 
Immunoblot Analysis of MoAb F12 and Paraneoplastic 
Pemphigus Sera MoAb F12 was previously demonstrated to 
recognize a 185-kD polypeptide by immunoblot analysis using bo-
vine tongue epithelium as the substrate [5) . Two paraneoplastir 
pemphigus sera and MoAb F12 were tested by this procedure on the 
same extract of bovine tongue epithelium. Figure 4 shows that IgG 
autoantibodies present in the paraneoplastic pemphigus sera reacted 
with a 185-kD polypeptide that co-migrated with the band recog-
nized by MoAb F12. In contrast, when goat anti-human IgM was 
used as the second antibody, no band could be detected in these tW() 
paraneoplastic pemphigus sera or in the serum of the patient from 
whom the F12 MoAb was derived . 
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Figure 3. Indirect immunoelectron microscopy. A) Sraining of desmosomal plaques by MoAb F12 (arrow); illsert, negarive control experiment using an 
irrelevant human IgM MoAb (bar, 80 nm) and B) hemidesmosomes of normal human skIn were also labeled by MoAb F12 (arrow) (bar, 440 nm); C) 
paraneoplast~c pemphigus serum stained the hemidemloso~les of the dermal-ep,dermalJun~tlon, glvmg a pattern similar to that ofF12 (bar, 450 nm); D) on a 
rat liver section, MoAb F12 bound to adherens-typeJunctlOns between hepatocytes and bile duct cells (arrow) (bar, 320 nm). 
In addition, pre-incubation of the nitrocellulose strips with a 
paraneoplastic pemphigus patient serum inhibited the binding of 
MoAb F12 to the 185-kD band, whereas no inhibition was given by 
a normal human serum (data not shown). 
DISCUSSION 
We recently reported the production of a human IgM, kappa 
MoAb, derived from a young patient with pemphigus vulgaris, that 
binds to the cell membrane of stratified squamous epithelia and 
reacts with a 185-kD polypeptide by immunoblot analysis [5). By 
lIF, this MoAb stained the cell membrane ofkeratinocytes as wel l as 
the BMZ on human skin sections. This IIF pattern differed from 
that usually seen with pemphigus vulgaris sera. These data should 
be considered in light of the characteristics described for sera from 
para neoplastic pemphigus patients. They labeled the "intercellular 
substance" and BMZ by IIF and immunoprecipitated an antigenic 
complex including an unidentified polypeptide of 190 kD and 
probably lower molecu lar mass [9]. 
We first examined the tissue distribution of the target antigen 
recognized by MoAb F12 and determined its ultralocalization by 
IIEM. Immunofluorescence experiments showed that stratified 
squamous epithelia, non-squamous epithelia, and non-epithelial 
tissues were labeled by the MoAb, indicating that this autoantibody 
recognized an antigenic determinant of the adhesion junctions 
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Figure 4. Immunoblot analysis using bovine tongue epithelium extracts as 
the antigen. Lane A, anti-des rnoglein MoAb (160-kD band); In lie B, anti-des-
moplakin MoAb (250 - 220-kD bands; laltes A, B, goat anti-murine IgG was 
used as the second antibody); {ane C, MoAb F12 (1 85-kD band; goat anti-hu-
man IgM was used as the second antibody); lOlle D, serum from the pemphi-
gus vulgaris patient from whom MoAb F12 was derived (130- and 185-kD 
bands); lOlles E, F~ sera from paraneoplastic pemphigus patients (250-, 220-, 
and 185-kD bands). Lalle G, serum from a healthy individual. For lalles 
D -G, goat anti -human IgG was used as the second antibody. 
common to different epithelia and tissues. HEM analysis demon-
strated that MoAb F12 recognized an antigen associated with des-
mosomes and, more precisely, with the intracytoplasmic part of the 
desmosomes, because it stained the desmosomal plaques and not the 
desmoglea. 
The immunochemical properties of MoAb F12 were different 
from those of autoantibodies present in pemphigus vulgaris and 
pemphigus foliaceus sera [10-1 3]. These latter autoantibodies give 
an intercellular substance fluorescent staining limited to stratified 
squamous epithelia and bound predominantly to the extracellular 
portion of desmosomes by HEM [14,151, whereas MoAb F12 bound 
to both the cell membrane of kera tinocytes and BMZ by IIF and 
labeled desmosomal plaques but not the desmoglea. However, 
MoAb F12 shares some immunochemical properties with autoanti-
bodies present in paraneoplastic pemphigus sera . First, lIF analysis 
demonstrated that autoantibodies present in paraneoplastic pem-
phigus sera and MoAb F12 bound to squamous and non-squamous 
epithelia and non-epithelial substrates. Second, !IEM study showed 
that the staining of hemidesmosomes observed with paraneoplastic 
pemphigus sera was similar to that seen with MoAb F12. In addi-
tion, paraneoplastic pemphigus sera stained the extracellular part of 
desmosomes as well as the desmosomal plaques (P. Joly, manuscript 
in preparation), this latter pattern being very similar to that observed 
with MoAb F12. Therefore, MoAb F12 might have the same anti-
gen specificity as the autoantibody population participating in the 
complex autoimmune response that characterizes para neoplastic 
pemphigus. 
The relationship between MoAb F12 and autoantibodies present 
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in paraneoplas tic pemphigus patients is further supported by immu-
nofluorescence blocking experiments and Western blot analysis. 
Only three sera among the 18 autoimmune blistering disease sera 
tested were able to block the binding of the MoAb F12 to human 
epidermis; one came from the pemphigus vulgaris patient from 
whom the secreting hybridoma F12 was derived and the two others 
were from paraneoplastic pemphigus patients. In addition, Western 
blot analysis showed that IgG autoantibodies present in these three 
sera recognized a 185-kD band that co-migrated with the polypep-
tide bound by MoAb F12. 
The protein recognized by MoAb F12 remains unidentified. The 
185-kD molecular mass of the polypeptide, the inability of the 
anti-desmoglein I murine MoAb to block F12 reactivity , and the 
HEM data clearly indicate that the target antigen is different from 
desl11og1ein. Desmoplakin, which is a major component of desmo-
somal plaques, might be considered as a candidate [16] . Indeed, this 
protein is not a component of hemidesmosomes and has a 250-kD 
molecular mass. One should keep in mind, however, that some 
antibodies directed against desmoplakin I-H have been demon-
strated to react with hemidesmosome plaques [17] and that desmo-
plakin has regions of marked homology with the 230-kD antigen of 
bullous pemphigoid [18] . Moreover, it has been demonstrated that 
desmosomal plaque contains cytoplasmic proteins that are common 
to different types of ad hesion junctions including epithelial and 
myocardial desmosomes and non-desmosomal plaque structures of 
hepatocellular carcinoma cell lines [19 - 21] . Therefore, it is possible 
that the 185-kD band corresponds to a degradation product of des-
moplakin. However, the absence of binding of the murine anti-des-
moplakin MoAb to the 185-kD polypeptide and the inability of this 
MoAb to block F12 reactivity on human epidermis strongly argue 
against this hypothesis. 
It is striking that MoAb F12 was derived from a 14-year-old 
female with typical pemphigus vulgaris, in whom we failed to dem-
onstrate neoplasia. Anti-ICS IgG autoantibodies present in her 
serum bound to a 130-kD polypeptide characteristic of the pemphi-
gus vulgaris antigen and to the 185-kD polypeptide. The 130-kD 
polypeptide is usual! y not recognized by autoantibodies present in 
the sera of patients with paraneoplastic pemphigus (4]. This obser-
vation argues for an overlapping distribution of autoantibody speci-
ficities between paraneoplastic pemphigus and some pemphigus 
vulgaris, as has been described between pemphigus foliaceus and 
pemphigus vulgaris sera [2,22}. Therefore, olle could hypothesize 
that this 185-kD protein might be a minor antigen component that 
is mainly recognized by paraneoplastic pemphigus sera. 
Further investigation is underway in our laboratory to identify 
the 185-kD antigen and determine the clinica.l significance of the 
anti - 185-kD autoantibody population. 
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